These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 26375384)
1. Supramolecular Organization and siRNA Binding of Hyaluronic Acid-Coated Lipoplexes for Targeted Delivery to the CD44 Receptor. Nascimento TL; Hillaireau H; Noiray M; Bourgaux C; Arpicco S; Pehau-Arnaudet G; Taverna M; Cosco D; Tsapis N; Fattal E Langmuir; 2015 Oct; 31(41):11186-94. PubMed ID: 26375384 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells. Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532 [TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor. Dufaÿ Wojcicki A; Hillaireau H; Nascimento TL; Arpicco S; Taverna M; Ribes S; Bourge M; Nicolas V; Bochot A; Vauthier C; Tsapis N; Fattal E J Control Release; 2012 Sep; 162(3):545-52. PubMed ID: 22820451 [TBL] [Abstract][Full Text] [Related]
4. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes. Choi KM; Jang M; Kim JH; Ahn HJ Biomaterials; 2014 Aug; 35(25):7121-32. PubMed ID: 24854094 [TBL] [Abstract][Full Text] [Related]
5. Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells. Surace C; Arpicco S; Dufaÿ-Wojcicki A; Marsaud V; Bouclier C; Clay D; Cattel L; Renoir JM; Fattal E Mol Pharm; 2009; 6(4):1062-73. PubMed ID: 19413341 [TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid-conjugated lipoplexes for targeted delivery of siRNA in a murine metastatic lung cancer model. Leite Nascimento T; Hillaireau H; Vergnaud J; Rivano M; Deloménie C; Courilleau D; Arpicco S; Suk JS; Hanes J; Fattal E Int J Pharm; 2016 Nov; 514(1):103-111. PubMed ID: 27863652 [TBL] [Abstract][Full Text] [Related]
7. A New Hyaluronic Acid Derivative Obtained from Atom Transfer Radical Polymerization as a siRNA Vector for CD44 Receptor Tumor Targeting. Palumbo FS; Bavuso Volpe A; Bongiovì F; Pitarresi G; Giammona G Macromol Biosci; 2015 Nov; 15(11):1605-15. PubMed ID: 26136372 [TBL] [Abstract][Full Text] [Related]
8. Reducible hyaluronic acid-siRNA conjugate for target specific gene silencing. Park K; Yang JA; Lee MY; Lee H; Hahn SK Bioconjug Chem; 2013 Jul; 24(7):1201-9. PubMed ID: 23731084 [TBL] [Abstract][Full Text] [Related]
9. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance. Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564 [TBL] [Abstract][Full Text] [Related]
10. PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy. Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Fu H; Zhang Z; He Q J Pharm Sci; 2015 Feb; 104(2):476-84. PubMed ID: 25256603 [TBL] [Abstract][Full Text] [Related]
11. A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery. Shen Y; Wang B; Lu Y; Ouahab A; Li Q; Tu J Int J Pharm; 2011 Jul; 414(1-2):233-43. PubMed ID: 21545832 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Jiang G; Park K; Kim J; Kim KS; Oh EJ; Kang H; Han SE; Oh YK; Park TG; Kwang Hahn S Biopolymers; 2008 Jul; 89(7):635-42. PubMed ID: 18322932 [TBL] [Abstract][Full Text] [Related]
13. HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery. Almalik A; Day PJ; Tirelli N Macromol Biosci; 2013 Dec; 13(12):1671-80. PubMed ID: 24106105 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid-coated liposomes for active targeting of gemcitabine. Arpicco S; Lerda C; Dalla Pozza E; Costanzo C; Tsapis N; Stella B; Donadelli M; Dando I; Fattal E; Cattel L; Palmieri M Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):373-80. PubMed ID: 23791684 [TBL] [Abstract][Full Text] [Related]
15. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex. Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990 [TBL] [Abstract][Full Text] [Related]
16. Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy. Martens TF; Remaut K; Deschout H; Engbersen JF; Hennink WE; van Steenbergen MJ; Demeester J; De Smedt SC; Braeckmans K J Control Release; 2015 Mar; 202():83-92. PubMed ID: 25634806 [TBL] [Abstract][Full Text] [Related]
17. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Spagnou S; Miller AD; Keller M Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141 [TBL] [Abstract][Full Text] [Related]
18. Complexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparation. Barichello JM; Ishida T; Kiwada H Methods Mol Biol; 2010; 605():461-72. PubMed ID: 20072901 [TBL] [Abstract][Full Text] [Related]
19. A physicochemical characterization of the interaction between DC-Chol/DOPE cationic liposomes and DNA. Rodríguez-Pulido A; Ortega F; Llorca O; Aicart E; Junquera E J Phys Chem B; 2008 Oct; 112(39):12555-65. PubMed ID: 18729499 [TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-siRNA conjugate/reducible polyethylenimine complexes for targeted siRNA delivery. Jang YL; Ku SH; Jin S; Park JH; Kim WJ; Kwon IC; Kim SH; Jeong JH J Nanosci Nanotechnol; 2014 Oct; 14(10):7388-94. PubMed ID: 25942799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]